The Alzheimer disease BIN1 locus as a modifier of GBA-associated Parkinson disease

Journal of Neurology

Volumn 262, Issue 11, 2015, Pages 2443-2447

  Gan Or, Z ^a,b   Amshalom, I ^a,b   Bar Shira, A ^a   Gana Weisz, M ^a   Mirelman, A ^a   Marder, K ^c   Bressman, S ^d   Giladi, N ^a,b   Orr Urtreger, A ^a,b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

BIN1; GBA; Genetics; Parkinson disease

Indexed keywords

BRIDGING INTEGRATOR 1 PROTEIN; GLUCOSYLCERAMIDASE; PROTEIN; UNCLASSIFIED DRUG; BIN1 PROTEIN, HUMAN; NUCLEAR PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ALLELE; ALZHEIMER DISEASE; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; GENE LOCUS; GENE MUTATION; GENE REPLICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MARKER; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MODIFIER GENE; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; GENETICS; GENOME-WIDE ASSOCIATION STUDY; MIDDLE AGED; MUTATION; SEVERITY OF ILLNESS INDEX;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGE OF ONSET; AGED; ALZHEIMER DISEASE; GENES, MODIFIER; GENOME-WIDE ASSOCIATION STUDY; GLUCOSYLCERAMIDASE; HUMANS; MIDDLE AGED; MUTATION; NUCLEAR PROTEINS; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; SEVERITY OF ILLNESS INDEX; TUMOR SUPPRESSOR PROTEINS;

EID: 84956773191     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-015-7868-3     Document Type: Article

References (16)

1. Sidransky E, Nalls MA, Aasly JO et al (2009) Multicenter analysis of glucocerebrosidase mutations in Parkinson’s disease. N Engl J Med 361:1651–1661
2. Gan-Or Z, Giladi N, Rozovski U et al (2008) Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset. Neurology 70:2277–2283
3. Gan-Or Z, Amshalom I, Kilarski LL et al (2015) Differential effects of severe vs mild GBA mutations on Parkinson disease. Neurology 84(9):880–887
4. Gan-Or Z, Bar-Shira A, Gurevich T et al (2011) Homozygosity for the MTX1 c.184T>A (p. S63T) alteration modifies the age of onset in GBA-associated Parkinson’s disease. Neurogenetics 12:325–332
5. Voight BF, Pritchard JK (2005) Confounding from cryptic relatedness in case-control association studies. PLoS Genet 1(3):e32
6. Vacic V, Ozelius LJ, Clark LN et al (2014) Genome-wide mapping of IBD segments in an Ashkenazi PD cohort identifies associated haplotypes. Hum Mol Genet 23(17):4693–4702
7. Nalls MA, Pankratz N, Lill CM et al (2014) Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease. Nat Genet 46:989–993
8. Gan-Or Z, Bar-Shira A, Mirelman A et al (2012) The age at motor symptoms onset in LRRK2-associated Parkinson’s disease is affected by a variation in the MAPT locus: a possible interaction. J Mol Neurosci 46:541–544
9. Golub Y, Berg D, Calne DB et al (2009) Genetic factors influencing age at onset in LRRK2-linked Parkinson disease. Parkinsonism Relat Disord 15:539–541
10. Seshadri S, Fitzpatrick AL, Ikram MA et al (2010) Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 303:1832–1840
11. Jun G, Ibrahim-Verbaas CA, Vronskaya M et al (2015) A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry. doi:10.1038/mp.2015.23
12. Moskvina V, Harold D, Russo G et al (2013) Analysis of genome-wide association studies of Alzheimer disease and of Parkinson disease to determine if these 2 diseases share a common genetic risk. JAMA Neurol 70(10):1268–1276
13. Lambert JC, Ibrahim-Verbaas CA, Harold D et al (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat Genet 45(12):1452–1458
14. Tan MS, Yu JT, Tan L (2013) Bridging integrator 1 (BIN1): form, function, and Alzheimer’s disease. Trends Mol Med 19:594–603
15. Pienaar IS, Burn D, Morris C et al (2012) Synaptic protein alterations in Parkinson’s disease. Mol Neurobiol 45:126–143
16. Nicot AS, Toussaint A, Tosch V et al (2007) Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy. Nat Genet 39:1134–1139